Drug · DIN 02559595
BUCCOLAM
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 20, 2026; first marketed February 20, 2026.
- Drug Identification Number (DIN)
- 02559595
- Company (DIN owner)
- Neuraxpharm Pharmaceuticals, S.L.Sant Joan Despi, Barcelona, Spain
- Schedule
- Targeted substances (CDSA IV)
- Dosage form
- Solution
- Route
- Buccal
- Therapeutic class (ATC)
- Midazolam N05CD08
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 7.5 MG | 1.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 22, 2025: NOC 35718New Drug Submission (NDS)
Other DINs named BUCCOLAM
- DIN 02559579 · Marketed
- DIN 02559587 · Marketed
- DIN 02559609 · Marketed